SVA down over 33% since the 42M volume day on Sept. 1st spiked it to $12.50
The retracement has now fully been put in place. The institutional investors now should start to build positions as the retail investors have been forced out with the steady walk down.
The cold season is just weeks away and cold symptons should start to set a panic in for H1N1 flu shots.
I would not be caught not holding shares of SVA at this low price ahead of the flu season.